Skip to main content

Table 1 Clinical and demographical characteristics of patients

From: Evaluation of temporomandibular joint involvement in juvenile idiopathic arthritis patients

 

n (%)

Gender

 Male

20 (48.7%)

 Female

21 (51.2%)

Age (y) (median, IQR)

11.55 ± 4.21 (3.6–17.3)

Age at Diagnosis

 Early-Onset

18 (43.9%)

 Late-Onset

23 (56.01%)

Disease Duration (y) (median, IQR)

3.16 ± 1.05 (0.5-7)

JIA Subtype

 Oligoarticular Onset

13 (31.7%)

 Polyarticular Onset

15 (36.5%)

 Systemic Onset

5 (12.1%)

 Enthesitis-Related

4 (9.7%)

 Juvenile Psoriatic Arthritis

0 (0.0%)

Number of Involved Joints

 1–4

18 (43.9%)

 ≥5

23 (56.01%)

ESR (mm/h)

 High (> 20)

22 (52.6%)

 Normal

19 (47.4%)

CRP (mg/dl)

 Positive (> 0.05)

19 (47.4%)

 Negative

22 (52.6%)

Treatment

 NSAID

31 (75.6%)

 DMARD

38 (92.6%)

 Steroids

30 (73.1%)

 Biological Agents

7 (17.0%)

Treatment Response

 Good

24 (58.5%)

 Poor

17 (41.5%)

  1. (CRP: C-Reactive Protein; dl: deciliter; ESR: Eritrocyte Sedimentation Rate; h: hour; IQR: Inter Quarteral Range; JIA: Juvenile Idiopathic Arthritis; mg: miligram; mm: millimeter; n: number; NSAID: Non Steroid Anti Inflammatory Drugs; DMARD: Disease Modifying Anti-Rheumatological Drugs; y: years)